LUMENSIA SENSORS offers its proprietary photonics-based biosensing platform for accurate, fast, low-cost and simple Identification and Quantification of biological targets for Health, Food Industry, Environment and Security sectors. LUMENSIA is rolling out SAPHER, the first biosensing platform for fast, multiple simultaneous assessment of allergens in food. LUMENSIA is working in the development of a simultaneous test for identification of SARS-COV-2 and its antibodies in human samples. Results expected in Autumn 2020. LUMENSIA’s sensing technology is based on Photonic Integrated Circuits (PICs) showing higher performances than the existent techniques for similar applications in the marketplace: multi-target sensing, high specificity and sensitivity, fast and reliable measurement, label-free and low-cost devices and consumables